Collectively, these studies provide compelling evidence that therapeutic strategies aimed at inducing HO-1 or reinforcing its upstream regulators may alleviate the oxidative and inflammatory milieu characteristic of preeclampsia, offering a promising avenue for disease prevention and treatment, as summarized in Table 1. This evidence concerns the gene HMOX1 and preeclampsia.